Abstract
The effects of thyrotropin-releasing hormone (TRH) on abrupt and naloxone-precipitated abstinece symptoms were determined in male Swiss-Webster mice rendered dependent on morphine by SC implantation of morphine pellets. Intracerebral (IC) administration of TRH inhibited the hypothermic response observed during abrupt (removal of morphine pellets) and naloxone (0.1 mg/kg SC) precipitated withdrawal. IC injection of TRH also inhibited the naloxoneprecipitated withdrawal jumping response as evidenced by increases in the dose of naloxone required to elicit the response. The effects of TRH on the development of morphine dependence were also investigated. A single SC injection of TRH (4–16 mg/kg) did not modify development of morphine dependence. Administration of TRH prior to and during morphine pellet implantation inhibited the development of dependence as evidenced by inhibition in the development of abrupt and naloxone-induced withdrawal hypothermia. Even though the hypothermic response was blocked, multiple SC administration of TRH failed to modify naloxone-induced stereotyped jumping response. These studies indicate that TRH administration can modify central nervous system responses to chronic morphine treatment and that separate sites may initiate withdrawal jumping behavior and affect temperature regulation during abrupt and antagonist-induced abstinence.
Similar content being viewed by others
References
Bhargava, H. N.: Rapid induction and quantitation of morphine dependence in the rat by pellet implantation. Psychopharmacology 52, 55–62 (1977)
Bhargava, H. N.: The effects of naltrexone on the development of physical dependence on morphine. Eur. J. Pharmacol. 50, 193–202 (1978a)
Bhargava, H. N.: Effects of methionine-enkephalin and morphine on spontaneous locomotor activity: Antagonism by naloxone. Pharmacol. Biochem. Behav. 9, 167–171 (1978b)
Bhargava, H. N., Matwyshyn, G. A.: Brain serotonin turnover and morphine tolerance and physical dependence induced by multiple injections in the rat. Eur. J. Pharmacol. 44, 25–33 (1977)
Bhargava, H. N., Way, E. L.: Acetylcholinesterase inhibition and morphine effects in morphine-tolerant and dependent mice. J. Pharmacol. Exp. Ther. 183, 31–40 (1972)
Bhargava, H. N., Way, E. L.: Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal. J. Pharmacol. Exp. Ther. 194, 65–73 (1975)
Bowers, C. Y., Friesen, H. G., Hwang, P., Guyda, H. J., Folkes, K.: Prolactin and thyrotropin release in man by synthetic pyroglutamylhistidylprolineamide. Biochem. Biophys. Res. Commun. 45, 1033–1041 (1971)
Breese, G. R., Cott, J. M., Cooper, B. R., Prange, A. J., Lipton, M. A.: Antagonism of ethanol narcosis by thyrotropin-releasing hormone. Life Sci. 14, 1053–1063 (1974)
Breese, G. R., Cott, J. M., Cooper, B. R., Prange, A. J., Lipton, M. A., Plotnikoff, N. P.: Effects of thyrotropin-releasing hormone on the actions of pentobarbital and other centrally acting drugs. J. Pharmacol. Exp. Ther. 193, 11–22 (1975)
Cott, J. M., Breese, G. R., Cooper, B. R., Barlow, T. S., Prange, A. J.: Investigations into the mechanisms of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH). J. Pharmacol. Exp. Ther. 196, 594–604 (1976)
Horita, A., Carino, M. A., Chestnut, R. M.: Influence of thyrotropin-releasing hormone on drug-induced narcosis and hypothermia in rabbits. Psychopharmacology 49, 57–62 (1976)
Kirk, R. E.: Experimental design: Procedures for the behavior sciences. Los Angeles: Brooks Cole 1968
Litchfield, J. T., Wilcoxon, F.: A simplified method for evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96, 99–113 (1949)
Martin, B. R., Dewey, W. L., Chau-Pham, T., Prange, A. J., Jr.: Interactions of thyrotropin-releasing hormone and morphine sulfate in rodents. Life Sci. 20, 715–722 (1977)
Plotnikoff, N. P., Prange, A. J., Breese, G. R., Anderson, M. S., Wilson, I. C.: Enhancement of Dopa activity by a hypothalamic hormone. Science 178, 417–418 (1972)
Plotnikoff, N. P., Prange, A. J., Breese, G. R., Anderson, M. S., Wilson, I. C.: The effects of TRH on Dopa responses in normal hypophysectomized and thyroidectomized animals. In: The thyroid axis: Drugs and behavior, A. J. Prange, ed., pp. 103–113 New York Raven 1974a
Plotnikoff, N. P., Prange, A. J., Breese, G. R., Wilson, I. C.: Thyrotropin-releasing hormone: Enhancement of Dopa activity in thyroidectomized rats. Life Sci. 14, 1271–1278 (1974b)
Prange, A. J., Breese, G. R., Martin, B. R., Cooper, B. R., Wilson, I. C., Plotnikoff, N. P.: Thyrotropin-releasing hormone: Antagonism of pentobarbital in rodents. Life Sci 14, 447–455 (1974)
Schulz, R., Blasig, J., Laschka, E., Herz, A.: Sites of naloxoneprecipitated opiate withdrawal dissociates from that at which apomorphine reinitiates this phenomenon. Naunyn Schmiedebergs Arch. Pharmacol. 305, 1–4 (1978)
Walter, R., Ritzmann, R. F., Bhargava, H. N., Flexner, L. B.: Prolylleucylglycinamide, cyclo(leucylglycine), and derivatives block the development of physical dependence on morphine in mice. Proc. Nat. Acad. Sci. USA 76, 518–520 (1979)
Way, E. L., Loh, H. H., Shen, F. H.: Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167, 1–8 (1969)
Wei, E., Sigel, S., Loh, H. H., Way, E. L.: Thyrotropin-releasing hormone and shaking behavior in rat. Nature 253, 739–740 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bhargava, H.N. The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration. Psychopharmacology 68, 185–189 (1980). https://doi.org/10.1007/BF00432139
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432139